Seagen Inc.
Glycan-Interacting Compounds and Methods of Use

Last updated:

Abstract:

The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include humanized antibodies, derivatives and fragments thereof as well as related compositions and kits. Methods of using glycan-interacting antibodies for treatment and diagnosis are included.

Status:
Application
Type:

Utility

Filling date:

1 Dec 2021

Issue date:

18 Aug 2022